Seems to form a single continuous helix according to predictions. Kinetoplastid-only protein.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4HH84
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 14 | 18 | PF00656 | 0.731 |
CLV_C14_Caspase3-7 | 160 | 164 | PF00656 | 0.509 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.437 |
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.749 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.453 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.469 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.472 |
CLV_PCSK_FUR_1 | 141 | 145 | PF00082 | 0.681 |
CLV_PCSK_FUR_1 | 94 | 98 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.737 |
CLV_PCSK_KEX2_1 | 37 | 39 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.501 |
CLV_PCSK_PC1ET2_1 | 96 | 98 | PF00082 | 0.501 |
DEG_APCC_DBOX_1 | 101 | 109 | PF00400 | 0.718 |
DEG_SPOP_SBC_1 | 75 | 79 | PF00917 | 0.705 |
DOC_MAPK_gen_1 | 109 | 117 | PF00069 | 0.558 |
DOC_MAPK_MEF2A_6 | 109 | 117 | PF00069 | 0.558 |
DOC_PP2B_LxvP_1 | 44 | 47 | PF13499 | 0.748 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.498 |
DOC_USP7_MATH_1 | 167 | 171 | PF00917 | 0.518 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.708 |
LIG_14-3-3_CanoR_1 | 102 | 108 | PF00244 | 0.696 |
LIG_14-3-3_CanoR_1 | 11 | 19 | PF00244 | 0.623 |
LIG_14-3-3_CanoR_1 | 151 | 157 | PF00244 | 0.516 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.782 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.723 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.672 |
LIG_LIR_Apic_2 | 127 | 133 | PF02991 | 0.397 |
LIG_Pex14_2 | 118 | 122 | PF04695 | 0.330 |
LIG_SH2_NCK_1 | 149 | 153 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.575 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.494 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.557 |
MOD_CK1_1 | 103 | 109 | PF00069 | 0.554 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.784 |
MOD_Cter_Amidation | 35 | 38 | PF01082 | 0.382 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.549 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.697 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.479 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.602 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.698 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.786 |
MOD_N-GLC_1 | 103 | 108 | PF02516 | 0.506 |
MOD_N-GLC_1 | 67 | 72 | PF02516 | 0.435 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.808 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.564 |
MOD_PKA_1 | 53 | 59 | PF00069 | 0.593 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.733 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.648 |
MOD_Plk_1 | 103 | 109 | PF00069 | 0.705 |
MOD_Plk_2-3 | 157 | 163 | PF00069 | 0.384 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.705 |
MOD_SUMO_rev_2 | 70 | 78 | PF00179 | 0.729 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.444 |
TRG_ER_diArg_1 | 141 | 144 | PF00400 | 0.469 |
TRG_NLS_MonoExtN_4 | 57 | 63 | PF00514 | 0.623 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8C6 | Leptomonas seymouri | 59% | 100% |
A0A0S4ISL6 | Bodo saltans | 41% | 100% |
A0A1X0NZL1 | Trypanosomatidae | 48% | 100% |
A0A3S7X2B4 | Leishmania donovani | 71% | 100% |
A4I4D0 | Leishmania infantum | 72% | 100% |
C9ZL34 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9ADS9 | Leishmania major | 71% | 97% |
E9AM01 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |